课题基金 / 基金详情

Enhancement, mapping, and validation of viral vectors for primate optogenetics

Enhancement, mapping, and validation of viral vectors for primate optogenetics
用于灵长类光遗传学的病毒载体的增强、绘图和验证
批准号:
10391957
负责人:
Marc A Sommer
金额:
$68.87万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-01-15 至 2026-12-31

项目摘要

项目成果

Marc A Sommer的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY Mapping the visual and visuomotor circuits of the brain using opsins and other actuators to target and control neurons is a central goal of modern neuroscience. Actuators have become key to studying neuronal circuits, modeling brain disorders, and developing new therapies. Neural actuator applications to research in rodents and other small animals have achieved great success. In primates, however, these approaches have yet to be transformative. The main problem is that viral vectors are required to deliver actuator genes, but both viral transduction and gene expression have been unreliable across, and even within, primate labs. Efficacy is hindered by the complex innate and adaptive retaliatory immune response in primates, and even when the approach does work, cell-type specificity is lacking. The overall purpose of this project is to incorporate recent advances in virology, gene therapy, and immunology to maximize viral transduction, maintain chronic gene expression, and gain cell-type specificity through retrograde transportation of viruses in visual circuits of the macaque brain. Throughout the project, optogenetics is the actuator-mediated intervention and the visual- oculomotor system is the testbed. We focus on two viruses that provide retrograde transport: retrograde adeno- associated virus-2 (rAAV2-retro) and fusion glycoprotein-E pseudotyped lentiviral vector (NeuRet). Each will deliver genes encoding the Red-activatable Channelrhodopsin (ReaChR). Our team, spanning Duke, NYU, and UNC-Chapel Hill, has extensive expertise in vector technology and macaque neurobiology. Aim 1 is dedicated towards the maturation of pharmacological regimens that modify both arms of the primate's immune system to enhance viral transduction and promote long-term constitutive expression of opsin transgenes. Aim 2 will establish comprehensive expression maps of retrogradely transduced neurons. This mapping is a critical step toward providing cell- and circuit-level specificity and supplies a means for physiologically identifying neurons, through phototagging, based on their anatomical connectivity. Aim 3 will use phototagging paired with projection targeting to identify and neurophysiologically characterize neurons contributing to specific circuits within the visual and visuomotor circuitry of the macaque brain. In combination, this work will enhance the efficacy of viral vectors for neuroscientific research of the macaque visual and visuomotor system, provide both anatomical and functional validation of the developed protocols, and provide new insights into the functional role these specific circuits serve in vision and visuomotor behaviors. Finally, this project will provide fundamental insights for improving human gene therapies that depend on viral delivery of therapeutic genes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enhancement, mapping, and validation of viral vectors for primate optogenetics
  • 批准号:
    10546445
  • 项目类别:
  • 资助金额:
    $64.21万
  • 财政年份:
    2022
  • 负责人:
    Marc A Sommer
  • 依托单位:
Neuromuscular Control of Primate Eye Movements
  • 批准号:
    9919573
  • 项目类别:
  • 资助金额:
    $19.7万
  • 财政年份:
    2019
  • 负责人:
    Marc A Sommer
  • 依托单位:
2017 Eye Movements Gordon Research Conference and Gordon Research Seminar
  • 批准号:
    9331202
  • 项目类别:
  • 资助金额:
    $5.5万
  • 财政年份:
    2017
  • 负责人:
    Marc A Sommer
  • 依托单位:
Impact of Timing, Targeting, and Brain State on rTMS of Human and Non-Human Primates
  • 批准号:
    9390539
  • 项目类别:
  • 资助金额:
    $301.62万
  • 财政年份:
    2017
  • 负责人:
    Marc A Sommer
  • 依托单位:
海外基金